KRAS and pancreatic neoplasm: Myc is overexpressed in many cancers, and its importance in pancreatic cancer has recently been underscored by the observation that Myc activation is sufficient to drive indolent, Kras mutant, pancreatic intraepithelial neoplasm towards PDAC along with the associated stromal changes inherent to PDAC [99].